前列化浊胶囊治疗湿热瘀滞型慢性前列腺炎的临床观察

目的观察前列化浊胶囊对湿热瘀滞型慢性前列腺炎患者的疗效。方法选择湿热瘀滞型慢性前列腺炎患者65例,随机分为两组,分别用前列化浊胶囊(治疗组)和前列解毒胶囊(对照组)治疗,疗程为1个月,在治疗前及治疗的第4周末进行慢性前列腺炎NIH-CPSI评分,并行SF-12量表评定。结果治疗组32例,治愈2例,显效15例,有效9例,无效6例,总有效率81.2%;对照组33例,治愈2例,显效5例,有效13例,无效13例,总有效率60.6%,两组总有效率比较差异有统计学意义(P<0.05);NIH-CPSI生活质量评分治疗组较对照组显著下降(P<0.05);SF-12体能组成量表(躯体不适感)总得分治疗组较对照组改善明显(P<0.05),SF-12智能组成量表(精神方面)总得分两组比较差异无统计学意义。结论前列化浊胶囊治疗湿热瘀滞型慢性前列腺炎疗效较好。

英文摘要:

Objective To evaluate the therapeutic effects of Qianlie Huazhuo Capsule(QHC)on patients with chronic prostatitis of’ dampness-heat stagnancy type(CP-DHS).Methods Sixty-five patients were randomly assigned to the treatment group(32 cases)treated with QHC and the control group(33 cases)treated with Qianlie Jiedu Capsule,for 1 month respectively.The clinical efficacy was evaluated at the end of the 2nd and 4th month, their quality of life(QOL)was estimated by NIH Chronic Prostatitis Syndrome Index(NIH-CPSI)and patients’ capacity was estimated by SF-12 scale as well.Results Out of patients in the treatment group,2 got cured,nota- ble effect showed in 15,effective in 9,and ineffective in 6,the total effective rate being 81.2%,while in the 33 patients of the control group,2 got cured,notable effect in 5,effective in 13 and ineffective in 13,the total effective rate 60.6%,the difference between the two groups was statistically significant in the total efficacy(P<0.05).As compared with the control group,the NIH-CPSI score for QOL was significantly lower,SF-12 physical capacity score was better in the treatment group(both P<0.05),and SF-12 mental capacity score in the two groups showed insignificant difference.Conclusion QHC could obtain good effect for the treatment of CP-DHS.

关闭